Press release content from Globe Newswire. The AP news staff was not involved in its creation.
aTyr Pharma Announces Promotion of Leslie Nangle, Ph.D., to Vice President of Research
aTyr Pharma, Inc.May 11, 2021 GMT
SAN DIEGO, May 11, 2021 (GLOBE NEWSWIRE) aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced the promotion of Leslie Nangle, Ph.D., to Vice President, Research. Dr. Nangle will serve as a member of the company’s executive leadership team, managing research and scientific operations. Dr. Nangle has served in scientific research roles at aTyr since joining the company in 2007, including most recently as Senior Director and Head of Research.
IsoPlexis Appoints Siddhartha Kadia to its Board of Directors
News provided by
Share this article
Share this article
BRANFORD, Conn., May 11, 2021 /PRNewswire/ IsoPlexis, the leader in functional single-cell proteomics, today announced the appointment of Siddhartha Kadia to its Board of Directors. Dr. Kadia joins IsoPlexis Board of Directors with over 20 years of experience in evolving a combination of technology, life science and healthcare industries.
Dr. Siddhartha Kadia previously served as the President of the Life Sciences division at Life Technologies, where he managed $2B P&L which consisted of some of the most recognized brands in the industry. Additionally, Dr. Kadia served as the President and Chief Executive Officer of EAG Laboratories, a global leader for scientific testing and materials analysis across industries from aerospace and agriculture to medical devices and pharmaceuticals. He has been involved in numerous mergers, acquisitions and integrations as a
A Coronavirus Variant First Found in India is Now Officially a Variant of Concern msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Credit Sergio Iñiguez, Ph.D.
EL PASO, Texas – Parents should know that an early introduction of antidepressants to children could lead to a lifetime of use, according to research by a psychology team from The University of Texas at El Paso that was published recently in Scientific Reports, a prestigious journal that is part of the Nature Publishing Group.
Sergio Iñiguez, Ph.D., associate professor of psychology and director of UTEP s Iñiguez Behavioral Neuroscience Lab, said that children who are prescribed medication such as Prozac for anxiety and depression may need to continue to use those products as adults to lead normal lives.
Funeral pyres of coronavirus victims at a makeshift crematorium in New Delhi on Sunday.Credit.Anindito Mukherjee/Getty Images
May 10, 2021
Amid a deepening crisis in India, the World Health Organization announced Monday that it had designated the B.1.617 variant, which has been growing more common in the country, as a variant of concern. Scientists still don’t know much about the variant, but they are worried that it might be helping to fuel the rise in the nation’s coronavirus infections, which experts say are probably undercounted.
“There is increased transmissibility demonstrated by some preliminary studies” of the variant, said Dr. Maria Van Kerkhove, the technical lead of the W.H.O.’s coronavirus response.